SecSonar.com

RadNet, Inc. (RDNT)

RadNet, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

RadNet, Inc. (RDNT) is a Medical - Diagnostics & Research company based in US with a market capitalization of $4.4B. Revenue grew 11.5% year-over-year and the company generated $85.6M in free cash flow. This page tracks RDNT's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 11K employees · IPO Jan 3, 1997

Valuation

Valuation & price

$52.39 · as of May 17, 2026 · -38.0% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

4.00

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$82.91$67.39$51.87Jul 25Dec 25Jul 26Jul 7, 25$55.26Jul 9, 25$57.62Jul 11, 25$55.48Jul 15, 25$55.46Jul 17, 25$58.84Jul 21, 25$57.94Jul 23, 25$58.54Jul 25, 25$57.41Jul 29, 25$56.54Jul 31, 25$54.73Aug 4, 25$55.77Aug 6, 25$52.96Aug 11, 25$62.00Aug 13, 25$68.41Aug 15, 25$67.45Aug 19, 25$67.93Aug 21, 25$68.61Aug 25, 25$69.59Aug 27, 25$71.29Aug 29, 25$71.76Sep 3, 25$70.95Sep 5, 25$71.41Sep 9, 25$73.08Sep 11, 25$73.73Sep 16, 25$74.36Sep 18, 25$76.58Sep 22, 25$75.64Sep 24, 25$75.54Sep 26, 25$75.91Sep 30, 25$76.21Oct 2, 25$78.33Oct 6, 25$78.29Oct 8, 25$76.08Oct 10, 25$70.60Oct 14, 25$73.81Oct 16, 25$77.39Oct 21, 25$80.16Oct 23, 25$82.88Oct 27, 25$81.63Oct 29, 25$78.84Oct 31, 25$75.99Nov 4, 25$78.49Nov 6, 25$78.91Nov 10, 25$80.85Nov 12, 25$74.45Nov 14, 25$75.15Nov 18, 25$79.16Nov 20, 25$79.26Nov 25, 25$82.91Nov 28, 25$82.79Dec 2, 25$78.80Dec 4, 25$81.08Dec 8, 25$76.16Dec 10, 25$77.13Dec 12, 25$73.94Dec 16, 25$71.22Dec 18, 25$71.40Dec 22, 25$74.68Dec 24, 25$72.94Dec 29, 25$72.81Jan 2, 26$70.95Jan 6, 26$77.36Jan 8, 26$78.38Jan 12, 26$76.35Jan 14, 26$72.90Jan 16, 26$70.99Jan 21, 26$72.00Jan 23, 26$73.17Jan 27, 26$72.50Jan 29, 26$70.71Feb 2, 26$70.87Feb 4, 26$67.68Feb 9, 26$69.15Feb 11, 26$69.47Feb 13, 26$69.54Feb 18, 26$71.63Feb 20, 26$70.08Feb 24, 26$67.79Feb 26, 26$72.09Mar 2, 26$75.22Mar 4, 26$71.33Mar 6, 26$60.68Mar 10, 26$60.83Mar 12, 26$59.78Mar 17, 26$63.63Mar 19, 26$62.64Mar 23, 26$61.74Mar 25, 26$60.66Mar 27, 26$56.15Mar 31, 26$55.89Apr 2, 26$54.79Apr 7, 26$54.58Apr 9, 26$56.07Apr 13, 26$56.23Apr 15, 26$58.22Apr 17, 26$60.39Apr 22, 26$57.83Apr 24, 26$57.63Apr 28, 26$57.89Apr 30, 26$56.55May 4, 26$58.26May 6, 26$58.64May 8, 26$58.19May 12, 26$56.00May 14, 26$53.43May 18, 26$54.17May 20, 26$54.21May 22, 26$54.40May 28, 26$55.31Jun 1, 26$52.89Jun 3, 26$51.87Jun 5, 26$54.34Jun 9, 26$56.18Jun 11, 26$58.20Jun 15, 26$57.05Jun 17, 26$52.82Jun 22, 26$55.76Jun 24, 26$58.16Jun 26, 26$60.74Jul 2, 26$68.75
$51.8752-week range$84.48
Loading valuation history…

Fundamentals

Key fundamentals

$4.4B

Market cap

11.5%

Revenue growth (YoY)

4.5%

Gross margin

$85.6M

Free cash flow (USD)

$1.1B

Net debt

3.0%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$884.5MFY 2017$922.2MFY 2018$975.1MFY 2019$1.2BFY 2020$1.1BFY 2021$1.3BFY 2022$1.4BFY 2023$1.6BFY 2024$1.8BFY 2025$2.0B
$884.5M$2B

Free cash flow by year

2016 → 2025

FY 2016$25.7MFY 2017$52.2MFY 2018$-28.6MFY 2019$3.0MFY 2020$108.3MFY 2021$-71.2MFY 2022$-103.0MFY 2023$44.3MFY 2024$45.0MFY 2025$85.6M
$25.7M$85.6M

Gross margin by year

2021 → 2025

FY 202114.6%FY 202211.6%FY 202313.7%FY 202413.6%FY 20254.5%
14.6%4.5%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

3

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 11, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $145KSWARTZ DAVID L · Director · $145.4KJun 22, 2026Filing
  • Insider sellInsider Sell $276KWesdorp Cornelis · Pres & CEO, Digital Health · $276KJun 18, 2026Filing
  • Insider sellInsider Sell $2.6MForthuber Stephen M · Pres & CEO-Eastern Operations · $2.6MJun 16, 2026Filing
  • 8-K eventDebt RefinancingJun 10, 2026Filing
  • 8-K eventAnnual Meeting ResultsJun 4, 2026Filing
  • 8-K eventIncremental Term Loan ProposalJun 3, 2026Filing
  • 8-K eventEarnings ReleaseMay 11, 2026Filing
  • Quarterly report10-Q FiledMay 11, 2026Filing

Questions

Frequently asked questions

What is RadNet, Inc.'s market cap?

RadNet, Inc. (RDNT) has a market capitalization of $4.4B.

What is RDNT's P/E ratio?

A meaningful P/E ratio is not available for RDNT — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is RDNT's price-to-book (P/B) ratio?

RDNT trades at 4.00 times book value per share.

Are insiders buying RDNT stock?

SEC Form 4 filings show no open-market insider buys at RadNet, Inc. in the last 90 days (3 sells).

Same arena

Related companies in Medical - Diagnostics & Research

TWST

Twist Bioscience Corporation

$4.3B

SHC

Sotera Health Company

$4.5B

GRAL

GRAIL, Inc.

$3.1B

NEOG

Neogen Corporation

$2B

CDNA

CareDx, Inc

$1.2B

QGEN

Qiagen N.V.

$7.6B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.